Mission First-in-Class Pipeline
Scioto is developing innovative therapies devoted to having a significant impact on the delivery of microbiome therapeutics.
Our unique Activated Bacterial Therapeutic (ABT) platform leverages live therapeutic bacteria biofilms pre-colonized on microspheres allowing for enhanced function and persistent benefit.
Research and Development